Welcome to our dedicated page for Datasea Intelligent Technology news (Ticker: DTSS), a resource for investors and traders seeking the latest updates and insights on Datasea Intelligent Technology stock.
Datasea Intelligent Technology Ltd. develops acoustic high-tech products and AI-powered multimodal digital solutions through a public holding-company structure. Its news commonly covers acoustic applications using ultrasonic, infrasound and directional sound technologies, including acoustic disinfection products, wellness care robots, environmental hygiene uses and research-stage industrial applications.
Company updates also address AI multimodal solution projects, 5G-AI digitalization, partner-supported commercialization, U.S. market activity through Datasea Acoustics LLC, and periodic financial results. The company completed a redomicile merger from Nevada to the British Virgin Islands in 2026, with the BVI company continuing as the Nasdaq-listed public holding company under DTSS.
Datasea Intelligent Technology (Nasdaq: DTSS) announced that CEO Zhixin Liu, who beneficially owns about 32% of shares and 49% of votes, adopted a Rule 10b5-1 plan to purchase up to US$1.0 million of Class A ordinary shares.
The purchases will use her personal funds, are not a company share repurchase, and do not use company cash or require board approval. Trades will occur over time, subject to market conditions, legal restrictions, the plan’s terms, and the Rule 10b5-1 cooling-off period, with no assurance any specific amount will be bought.
Datasea Intelligent Technology (NASDAQ:DTSS) is advancing preparatory compliance work for potential U.S. FDA establishment registration and device listing for an acoustic brain-computer interface product. The company has submitted a DUNS application and plans systematic documentation, testing and regulatory communication to support its acoustic medical and BCI internationalization strategy.
Datasea Intelligent Technology Ltd. (NASDAQ: DTSS) completed delivery of three AI multimodal solution projects with an aggregate contract value of RMB 6.9 million (≈USD 1.01 million).
The company said related revenue is expected to be recognized under applicable accounting standards. Effective April 16, 2026, Datasea completed a redomicile merger to the British Virgin Islands and its Class A shares continue trading on Nasdaq: DTSS.
Management highlighted these projects as furthering a transition to higher‑margin, solution‑driven revenue and expecting strong gross profit contribution.
Datasea (NASDAQ: DTSS) is advancing international commercialization of its acoustic AI wellness care robots and preparing a U.S. launch of acoustic disinfection products.
Products and services are deployed in >50 Chinese cities across ~300 locations, market cooperation exists across multiple Asian markets, and early U.S. pilots are underway. The Smart Air Sterilizer completed overseas testing and certification. Based on preliminary internal assessments, these initiatives may contribute up to $10 million incremental revenue next fiscal year, subject to significant uncertainties.
Datasea (NASDAQ: DTSS) announced initial U.S. commercial rollouts for its acoustic technology-enabled health and wellness care robots, developed with Yizhimei. Early-stage customer signings and deployments began in Boston, New Jersey, Los Angeles, and Phoenix and are intended to support initial service revenue generation and a scalable commercialization model.
The company provides core acoustic technology, technical service support, and scenario-based solutions to partners, while potential revenue streams may include technical service fees, solution integration income, and recurring service revenues tied to deployed terminals.
Datasea (NASDAQ: DTSS) announced initial technical service revenue and an expanded cooperation with Yizhimei to commercialize acoustic + AI health care robots for head-care and wellness applications. Products are deployed in >50 Chinese cities at ~300 locations and in multiple Asian markets, with targets of >3,000 domestic and ~1,500 international locations.
The collaboration moves from technology enablement to product commercialization, franchised chain deployment, and parallel domestic and overseas scaling.
Datasea (NASDAQ: DTSS) announced a foundational research breakthrough in ultrasonic-enhanced nanoscale precision control on February 18, 2026. The company says this establishes an engineering-level core technology architecture aimed at next-generation semiconductor manufacturing, currently in research and engineering validation and not yet commercialized.
Datasea plans further validation, modeling, and possible research collaborations while disclosing developments as appropriate.
Datasea (Nasdaq: DTSS) reported second fiscal quarter results for the six months ended Dec 31, 2025, showing a strategic shift toward higher‑margin technology businesses.
Revenue was approximately $26.81 million, down 35.46% YoY. Gross profit rose to $2.36 million (+284.4% YoY) and gross margin expanded 730 basis points to 8.8%, driven by cost efficiencies and a move away from low‑margin standardized services. Management highlighted continued investment in 5G+AI multimodal solutions and acoustic high‑tech R&D (acoustic medicine, brain–computer interfaces, intelligent acoustic systems).
Datasea (NASDAQ: DTSS) pre-announced unaudited results for the six months ended December 31, 2025. Revenue is expected to be approximately $26.68 million. Gross profit is expected to be approximately $2.32 million, up about 278% year-over-year, and gross margin expanded to 8.70% from 1.48% a year earlier. Management attributes the margin improvement to a reduction in low-margin standardized 5G AI services, higher contribution from customized 5G+AI solutions, advancement of acoustic high-tech products, and stricter cost controls. The company says it is shifting toward profitability optimization and exploring acoustic health-management and neuromodulation applications for future commercialization.
Datasea (NASDAQ:DTSS) and partner Yizhimei launched an 18-month channel execution plan to commercialize acoustic haircare robots, targeting phased deployment of ~10,000 effective market terminals across China.
The plan splits into a venue-owner channel (target ~3,000 health lifestyle venues; reference price ~RMB 19,800 / unit ≈ USD 2,840) and an adoption/penetration channel (target ~4,000 technical service arrangements with revenue-sharing). Datasea provides core acoustic technology and system integration; partner leads terminal deployment. Targets are for execution reference only, not performance guarantees. Market cited: China beauty & wellness ~RMB 1.5 trillion (≈USD 215 billion).